This comprehensive ethnicity assessment suggests comparable PK of ribociclib between Asian and non-Asian patients and supports current dose recommendations in Asian patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ji et al. (Wed,) studied this question.
synapsesocial.com/papers/69d892d16c1944d70ce04007 — DOI: https://doi.org/10.1016/j.clinthera.2026.03.004
Yan Ji
F. Sun
M. Sato
Clinical Therapeutics
Novartis (Switzerland)
National Taiwan University Hospital
Novartis (China)
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: